Thrombinoscope BV was founded in 2004 as a spin-off from the University of Maastricht. Since then the company has succesfully focused on becoming a worldwide leader in the field of thrombin generation. Through a network of specialized distributors and direct sales channels the Calibrated Automated Thrombogram (CAT) assay has become the standard all over the world. Thrombinoscope has further developed and optimized the method to a complete line of standardized reagents and user friendly software.
The company is dedicated to continuous innovation, which leads to new reagents, automated equipment and improved assays. The dedication to quality and continuous improvement has led to obtaining the ISO 13485 certification. Research and development is done through internal resources as well as close collaborations with renowned academic and clinical institutes. Although the CAT assay has proven to be a valuable and popular research tool in hundreds of laboratories throughout the world, we have the goal to introduce the CAT assay as a routine diagnostic tool in the future.
In 2009 Thrombinoscope joined the Stago Group. With over 350 marketed products and 2000 employees, Stago is a worldwide reference in Haemostasis and Thrombosis. The company is represented in over 110 countries via its affiliates and an extensive distribution network. The CAT assay is embedded in this structure which ensures efficient delivery and prompt service for our customers.